Mel270 and OMM1.3 models were classified as melanocytic and PKC inhibitor treatment over 24 h did not alter this differentiation status and the MP38 uveal melanoma cell line remained transitory in the presence of PKC inhibition (Fig. S3B). This evidence concerns the gene PRRT2 and uveal melanoma.